World's first corona vaccine arrived! Russian Federation successfully completes clinical trials

Henrietta Strickland
July 13, 2020

In June, the university entered into a partnership with CSL, an Australian biotech company, as well as the worldwide organisation spearheading the global approach to finding a vaccine, Coalition for Epidemic Preparedness Innovations (CEPI), in order to produce the millions of doses that would be required.

"Sechenov University has successfully completed trials on the world's first vaccine volunteers against coronaviruses" said Tarasov.

The research team - led by Kiat Ruxrungtham of the Chula Vaccine Research Centre - made the remark at a press conference charting progress in their work.

Chutitorn Ketloy, a research team member, said macaques which were vaccinated between May and June seem to have developed immunity against COVID-19, with their antibody levels reaching up to 5,120 after receiving the second dose.

The volunteers will be monitored while the safety and immune response of the vaccine will be analysed over a 12-month period.

"The Russian Health Ministry will make a decision on the substance effectiveness based on the results of" biochemical tests, the university said in a July 3 press release.

In light of this, it does appear that the two vaccine trials being sponsored by the Gamelaya Institute of Epidemiology and Microbiology have only concluded Phase I, which is to say that there is, quite likely, a long way to go before the vaccine candidate is authorised for distribution. A Phase I trial, typically, involves a smaller subset of volunteers that could range anywhere between 15 and 80 people.

A vaccine candidate has to undergo three different phases before it can be granted approval by a health regulatory authority such as the US' Food and Drug Administration.

He said the US FDA could exercise its Emergency Use Authorisation rule to produce vaccines in Thailand under the regulation and supervision of Thailand's FDA.

That's expected to happen later this year or in early 2021 if all goes according to plan.

The trial is expected to start in late July with at least five other large vaccine trials expected to be run through the COVID-19 Prevention Network and its more than 100 clinical trial sites.

Forbes reports that there is no indication as to when the vaccine will enter commercial production, but nevertheless this bodes well for the global fight against the virus. "The vaccine arrived when the crisis was already over", Dr Kiat said.

Other reports by Click Lancashire

Discuss This Article

FOLLOW OUR NEWSPAPER